Arch Biopartners Inc (ARCH.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 506 | 586 | 734 | 708 | 448 |
| Receivables | 87 | 1,221 | 1,213 | 795 | 2,201 |
| TOTAL | $622 | $1,848 | $2,002 | $1,515 | $2,668 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $622 | $1,848 | $2,002 | $1,515 | $2,668 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,100 | 1,027 | 1,002 | 1,024 | 1,802 |
| Accounts payable and accrued liabilities | 489 | 1,317 | 1,472 | 711 | 962 |
| Accrued Expenses | 190 | 116 | 77 | 464 | 425 |
| TOTAL | $2,779 | $2,460 | $2,551 | $2,198 | $3,189 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,313 | 3,361 | 3,361 | 3,361 | 3,362 |
| TOTAL | $2,313 | $3,361 | $3,361 | $3,361 | $3,362 |
| Total Liabilities | $5,092 | $5,820 | $5,912 | $5,559 | $6,551 |
| Shareholders' Equity | |||||
| Common Shares | 15,553 | 15,553 | 15,368 | 14,758 | 14,758 |
| Retained earnings | -24,724 | -24,226 | -23,979 | -23,491 | -23,316 |
| TOTAL | $-4,471 | $-3,973 | $-3,910 | $-4,045 | $-3,882 |
| Total Liabilities And Equity | $622 | $1,848 | $2,002 | $1,515 | $2,668 |